Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/APOLLOMICS-INC-152896960/news/Apollomics-Announces-the-First-Approval-of-Vebreltinib-for-MET-Exon-14-Skip-Non-Small-Cell-Lung-Canc-45373953/?utm_source=whatsapp&utm_medium=social&utm_campaign=share